American Journal of Bioethics
May 2, 2024
Edward Jacobs, B. Earp, Paul S. Appelbaum et al.
29 citations
A workshop on psychedelic ethics, the first Hopkins-Oxford Psychedelic Ethics (HOPE) meeting, was held in August 2023 at the University of Oxford to address ethical issues surrounding psychedelics. The organizers (BDE, DBY, EJ) aimed to foster interdisciplinary discussion on topics such as informed consent, therapeutic use, and societal implications. The report outlines the workshop's structure, key themes, and proposed guidelines for ethical research and practice in the field.
Drug Science Policy and Law
January 1, 2024
Ksenia Cassidy, C. J. Healy, Eva Henje et al.
10 citations
A history of childhood trauma does not increase the risk of having a challenging experience during acute ayahuasca effects, nor does it affect posttraumatic growth afterward. In a survey of 231 adults (average age 40, 48% women), those with childhood trauma histories reported no more adverse or challenging experiences during ayahuasca use than those without such histories. Additionally, the degree of challenge during the acute experience was not linked to greater ayahuasca-related posttraumatic growth. These findings suggest that childhood trauma exposure may not carry the same risk for poor treatment response to ayahuasca as it does for other interventions.
Frontiers in Psychology
March 15, 2021
Ingmar Gorman, Ingmar Gorman, Ingmar Gorman et al.
Psychedelic Harm Reduction and Integration (PHRI) is a clinical approach for mental health providers working with patients who use or consider using psychedelics in any setting. It combines harm reduction psychotherapy and psychedelic-assisted psychotherapy, applicable in brief or ongoing therapy. PHRI shifts from focusing only on negative outcomes and abstinence-based addiction treatment toward compassionate, destigmatizing acceptance of patients' choices. The approach addresses assessment, preparation, and managing difficult experiences, responding to increased psychedelic research, media attention, and legal changes.
Frontiers in Psychology
March 15, 2021
Ingmar Gorman, Ingmar Gorman, Ingmar Gorman et al.
Psychedelic Harm Reduction and Integration (PHRI) is a clinical approach for mental health providers working with patients who use or consider using psychedelics in any setting. It combines harm reduction psychotherapy and psychedelic-assisted psychotherapy, applicable in brief or ongoing therapy. PHRI shifts from focusing only on negative outcomes and abstinence-based addiction treatment toward compassionate, destigmatizing acceptance of patients' choices. The approach addresses assessment, preparation, and managing difficult experiences, responding to increased psychedelic research, media attention, and legal changes.